A comprehensive view of Cardiovascular / Heart Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Bristol-Myers Squibb Co. Amplifies Biopharmaceutical R&D Efforts with 50+ Molecules in Development, Champions Immunotherapy Education and Advocates for Heart Health

FDA accepts Sanofi's supplementary application for priority review of Dupixent as a potential treatment for moderate to severe chronic obstructive pulmonary disease with type 2 inflammation; a decision is expected by June 27, 2024

Novartis initiates Phase 3 clinical trial for pelacarsen in US Black/African American & hispanic populations with established atherosclerotic cardiovascular disease; trial yet to open for recruiting

AstraZeneca initiates a Phase 3 clinical trial to evaluate the effectiveness of baxdrostat in combination with dapagliflozin for treating chronic kidney disease in patients with high blood pressure; the trial will involve 2500 participants from the US

Bristol-Myers focuses on cardiovascular health education, collaborates with international associations for hypertrophic cardiomyopathy awareness, and highlights the role of community in cancer treatment; company also emphasizes mentorship in its R&D teams

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count